BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3329538)

  • 1. Intraperitoneal immunoglobulin (IG) treatment in prophylaxis of bacterial peritonitis in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Biomater Artif Cells Artif Organs; 1987; 15(1):151-9. PubMed ID: 3329538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy.
    Carozzi S; Nasini MG; Kunkl A; Cantarella S; Lamperi S
    ASAIO Trans; 1988; 34(3):635-9. PubMed ID: 3264176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.
    Keane WF; Comty CM; Verbrugh HA; Peterson PK
    Kidney Int; 1984 Mar; 25(3):539-43. PubMed ID: 6376908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritonitis prevention in CAPD.
    Carozzi S; Lamperi S
    Clin Nephrol; 1988; 30 Suppl 1():S45-8. PubMed ID: 3141093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma (IFN-gamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD).
    Lamperi S; Carozzi S
    Am J Kidney Dis; 1988 Mar; 11(3):225-30. PubMed ID: 3125740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal membrane defence mechanism in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Contrib Nephrol; 1987; 57():69-78. PubMed ID: 3315441
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis.
    Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB
    Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor resident peritoneal macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis.
    Lamperi S; Carozzi S
    Nephron; 1986; 44(3):219-25. PubMed ID: 2946966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.
    Cameron JS
    Pediatr Nephrol; 1995 Oct; 9(5):647-62. PubMed ID: 8580033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis.
    Coles GA; Alobaidi HM; Topley N; Davies M
    Nephrol Dial Transplant; 1987; 2(5):359-65. PubMed ID: 3122114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological defenses in CAPD.
    Lamperi S; Carozzi S
    Blood Purif; 1989; 7(2-3):126-43. PubMed ID: 2663033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Davies SJ; Yewdall VM; Ogg CS; Cameron JS
    Perit Dial Int; 1990; 10(2):135-40. PubMed ID: 2085598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Perit Dial Int; 1989; 9(2):115-9. PubMed ID: 2488196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonic activity of intravenous immunoglobulin preparations against Staphylococcus epidermidis.
    Clark LA; Easmon CS
    J Clin Pathol; 1986 Aug; 39(8):856-60. PubMed ID: 3745476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonic requirements of Staphylococcus epidermidis.
    Clark LA; Easmon CS
    J Med Microbiol; 1986 Aug; 22(1):1-7. PubMed ID: 3735386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 2. Humoral defenses.
    Holmes C; Lewis S
    Perit Dial Int; 1991; 11(2):112-7. PubMed ID: 1854866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain differences in the opsonisation of Staphylococcus epidermidis.
    Bennett-Jones DN; Yewdall VM; Gillespie CM; Ogg CS; Cameron JS
    Perit Dial Int; 1989; 9(4):333-9. PubMed ID: 2488390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
    Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic patterns in CAPD patients with peritonitis.
    Lamperi S; Carozzi S
    Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
    Vlaanderen K; de Fijter CW; Bos HJ; van der Meulen J; Beelen RH; Oe PL; Verbrugh HA
    Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.